Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400082718Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in gynaecological conditions (3 arms), sponsored by Second People's Hospital of Anhui Province. Primary endpoint: postoperative quality of recovery score. Planned start Apr 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400082718.